Rolling Meadows, Ill. (PRWEB) September 30, 2014

A first-of-its-kind scientific study reveals that dermatologists are the groundbreaking innovators in five of five categories of anti-aging injectable treatments for the face.

The evidenced-based study Who are the Pioneers? A Critical Analysis of Innovation and Expertise in Cutaneous Non-Invasive Procedures is examining all published research to determine which medical specialties have made the most advances in cosmetic treatments. The first study segment released today focuses on botulinum toxins and four types of soft-tissue fillers.

This first unbiased analysis of all existing scientific research will help consumers decide which specialist might be best for facial injectable treatments, said study author Omar A. Ibrahimi, M.D., Ph.D., director of the Connecticut Skin Institute in Stamford, Conn., and a member of the American Society for Dermatologic Surgery.

Consumers can be significantly confused because some cosmetic procedures are administered by physicians who are not board-certified dermatologists, and some are even offered by non-physicians, said Ibrahimi. This study is important because expertise and innovation often are judged by who has made the largest contributions to scientific research.

He said the thorough analysis of all peer-reviewed medial research on facial injectables finally answers the question of who are the innovators and the pioneers.

The answer for facial injectables is clearly dermatologists, said Ibrahimi. These data show the overwhelming majority of pioneering research in wrinkle-relaxers and fillers has been done by dermatologists. They are the leading innovators. Patients will know they are in the best hands with a dermatologist.

This first study segment includes botulinum toxins to ease facial lines (i.e., Botox, Dysport and Xeomin) as well as four types of soft-tissue fillers to smooth wrinkles and add facial volume. These include hyaluronic acid fillers (i.e., Juvederm, Restylane, Belotero and Voluma), calcium hydroxyapatite filler (i.e., Radiesse), poly-l lactic acid filler (i.e., Sculptra) and collagen fillers (i.e., Zyderm and Zyplast).

According to the scientific analysis, dermatologists are considered the pioneers in 10 of 10 measures using two scoring systems.

The overall project is using a ranking system for research studies. Those considered to be more valuable generally are cited more frequently by subsequent publications, Ibrahimi said. He and co-authors first sought to identify the most important research studies on injectable procedures, then analyzed the findings to determine the specialties whose members published the most significant research.

See the original post here:
Study: Dermatologists Pioneers of Injectables